Market Place
Sourcing Support
Click buys Better assets to speed its digital obesity drive
23 May 2024 //
PHARMAPHORUM
Click Acquires Better Therapeutics For Obesity Expansion
22 May 2024 //
BUSINESSWIRE
Better Therapeutics Announces Partnership with College of Lifestyle Medicine
05 Mar 2024 //
BUSINESSWIRE
Better Therapeutics Receives FDA Breakthrough Device Designation for Platform
20 Feb 2024 //
BUSINESSWIRE
Better Therapeutics Signs Agreement with One of the Pharmacy Benefit Managers
06 Feb 2024 //
BUSINESSWIRE
Better Therapeutics Announces Publication of Cost-Effectiveness Analysis
17 Jan 2024 //
BUSINESSWIRE
Better Therapeutics and Glooko Announce Partnership
04 Jan 2024 //
BUSINESSWIRE
Better Therapeutics and Glooko Announce Partnership
03 Jan 2024 //
BUSINESSWIRE
Frost & Sullivan Honors Better Therapeutics with Leadership Award
14 Nov 2023 //
BUSINESSWIRE
Better Therapeutics Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
BUSINESSWIRE
Better Therapeutics Announces New Data Highlighting Concurrent Use of AspyreRx
11 Oct 2023 //
BUSINESSWIRE
Better Completes Enrollment in Program Evaluating AspyreRx in Type 2 Diabetes
28 Sep 2023 //
BUSINESSWIRE
Better Therapeutics Reports Second Quarter 2023 Financial Results
09 Aug 2023 //
BUSINESSWIRE
Better Therapeutics Receives FDA Authorization for AspyreRx
10 Jul 2023 //
BUSINESSWIRE
Better Therapeutics Reports First Quarter 2023 Financial Results
11 May 2023 //
BUSINESSWIRE
Better Therapeutics to Release 1Q 2023 FYR & Business Update on May 11, 2023
04 May 2023 //
BUSINESSWIRE
Better Therapeutics lays off 35% of workforce
25 Mar 2023 //
FIERCE BIOTECH
Better Therapeutics to Release Fourth Quarter & Full Year 2022 Financial Results
23 Mar 2023 //
BUSINESSWIRE
Better Therapeutics to Participate in Two Upcoming Investor Conferences
09 Feb 2023 //
BUSINESSWIRE
Better Therapeutics to Participate in BTIG Digital Health Forum
15 Nov 2022 //
BUSINESSWIRE
Better Therapeutics to Release Third Quarter 2022 Financial Results
07 Nov 2022 //
BUSINESSWIRE
Positive Results from Trial of Better Therapeutics’ Investigational BT-001
04 Oct 2022 //
BUSINESSWIRE
Better Therapeutics Submits De Novo Request to U.S. FDA for BT-001
22 Sep 2022 //
BUSINESSWIRE
Better Tx Completes Pivotal Trial of BT-001 for Type 2 Diabetes and more
28 Jul 2022 //
BUSINESSWIRE
Better Tx to Publish on T2D Pivotal Trial of BT-001 in Clinical Cardiology
11 Jul 2022 //
BUSINESSWIRE
Better Therapeutics to Participate in Cowen’s Webinar on June 16, 2022
09 Jun 2022 //
BUSINESSWIRE
Better Therapeutics Gets U.S. Patent on Digital Therapeutics Platform
08 Jun 2022 //
BUSINESSWIRE
Better Tx to Host Virtual Educational Webinar Symposium in Diabetes Care
19 May 2022 //
BUSINESSWIRE
Better Tx to Host Call on Promising Results from Trial for Type 2 Diabetes
23 Mar 2022 //
BUSINESSWIRE
Better Therapeutics Completes Enrollment of Pivotal Trial for BT-001
18 Nov 2021 //
BUSINESSWIRE
Real-world evidence on Gilead`s Biktarvy confirms high efficacy; & more
29 Oct 2021 //
ENDPTS
Better Therapeutics Enrolls First Patient in Real-World Evidence Study of BT-001
19 Oct 2021 //
BUSINESSWIRE
Better Therapeutics Expands Real-World Evidence Study Initiative
24 Aug 2021 //
BUSINESSWIRE
